MX2011006903A - Vacuna recombinante de coriza infecciosa aviar y procedimiento para preparar la misma. - Google Patents
Vacuna recombinante de coriza infecciosa aviar y procedimiento para preparar la misma.Info
- Publication number
- MX2011006903A MX2011006903A MX2011006903A MX2011006903A MX2011006903A MX 2011006903 A MX2011006903 A MX 2011006903A MX 2011006903 A MX2011006903 A MX 2011006903A MX 2011006903 A MX2011006903 A MX 2011006903A MX 2011006903 A MX2011006903 A MX 2011006903A
- Authority
- MX
- Mexico
- Prior art keywords
- inclusion
- vaccine
- recombinant avian
- infectious coryza
- type
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 206010039083 rhinitis Diseases 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 230000004927 fusion Effects 0.000 abstract 3
- 241000588724 Escherichia coli Species 0.000 abstract 2
- 101710116435 Outer membrane protein Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 241000606767 Avibacterium paragallinarum Species 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Se proporcionan una vacuna de coriza infecciosa aviar recombinante y un procedimiento para preparar la misma; un procedimiento para preparar una vacuna de coriza infecciosa aviar recombinante la cual comprende el paso de construir E. coli que puede producirse como un cuerpo de inclusión, un péptido de fusión que consiste en péptidos derivados de la proteínas de membrana externa de serotipo A y serotipo C de Avibacterium paraqallinarum el paso de cultivar dicha E. coli y recolectar y purificar el cuerpo de inclusión del cultivo, y el paso de preparar una preparación que comprende dicho cuerpo de inclusión purificado, y una vacuna de coriza infecciosa aviar recombinante que comprende como un ingrediente activo el péptido de fusión; para el péptido derivado de los serotipos A y C, puede utilizarse una región de secuencia de aminoácidos de la Región 2 o su vecindad responsable para la protección de la infección.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008330448 | 2008-12-25 | ||
| PCT/JP2009/071398 WO2010074126A1 (ja) | 2008-12-25 | 2009-12-24 | 組換え鶏伝染性コリーザワクチン及びその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011006903A true MX2011006903A (es) | 2011-09-15 |
Family
ID=42287733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011006903A MX2011006903A (es) | 2008-12-25 | 2009-12-24 | Vacuna recombinante de coriza infecciosa aviar y procedimiento para preparar la misma. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8647634B2 (es) |
| EP (2) | EP2382985B1 (es) |
| JP (1) | JP5568017B2 (es) |
| KR (1) | KR101652060B1 (es) |
| CN (1) | CN102333539B (es) |
| BR (1) | BRPI0924068A2 (es) |
| ES (2) | ES2616533T3 (es) |
| MX (1) | MX2011006903A (es) |
| WO (1) | WO2010074126A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106267176B (zh) * | 2015-05-12 | 2020-03-10 | 普莱柯生物工程股份有限公司 | 鸡传染性鼻炎疫苗组合物及其制备方法和应用 |
| CN110540579B (zh) * | 2018-05-29 | 2022-09-06 | 普莱柯生物工程股份有限公司 | 一种副鸡禽杆菌抗原蛋白、含有副鸡禽杆菌抗原的疫苗组合物、及其制备方法和应用 |
| CN114573708B (zh) * | 2020-11-30 | 2024-05-17 | 普莱柯生物工程股份有限公司 | 副鸡禽杆菌ha融合蛋白及其三聚体、制备的疫苗组合物、制备方法和应用 |
| CN114262719B (zh) * | 2021-12-07 | 2023-05-16 | 扬州优邦生物药品有限公司 | 副鸡嗜血杆菌三价基因工程亚单位疫苗制备方法及运用 |
| CN117018174B (zh) * | 2023-08-28 | 2024-05-28 | 武汉科前生物股份有限公司 | 用于副鸡禽杆菌a型的酿酒酵母口服疫苗及应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58149956A (ja) | 1982-03-02 | 1983-09-06 | Sumitomo Chem Co Ltd | セルロ−ス系繊維の不均一染色法 |
| NZ219516A (en) | 1987-02-10 | 1991-02-26 | Wellcome Found | Fusion proteins of hbcag (hepatitis b virus core antigen) |
| IL99097A0 (en) * | 1990-09-05 | 1992-07-15 | Akzo Nv | Haemophilus paragallinarum vaccine |
| US6153406A (en) | 1993-07-23 | 2000-11-28 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B |
| GB9409962D0 (en) * | 1994-05-18 | 1994-07-06 | Smithkline Beecham Biolog | Novel compounds |
| JPH1084969A (ja) * | 1996-09-19 | 1998-04-07 | Chemo Sero Therapeut Res Inst | ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法 |
| GB0110431D0 (en) * | 2001-04-27 | 2001-06-20 | Glaxosmithkline Biolog Sa | Novel compounds |
| JP2004057078A (ja) | 2002-07-29 | 2004-02-26 | Nippon Inst For Biological Science | ヘモフィルス・パラガリナルム由来新規ポリペプチドとその遺伝子及び製法 |
| GB0220199D0 (en) | 2002-08-30 | 2002-10-09 | Univ Utrecht | Mutant protein and refolding method |
| AU2003269864A1 (en) | 2002-08-02 | 2004-02-25 | Glaxosmithkline Biologicals Sa | Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| JP3524546B2 (ja) * | 2003-06-18 | 2004-05-10 | 富士通株式会社 | 一覧表画面表示装置 |
| JP4001117B2 (ja) | 2004-02-09 | 2007-10-31 | 株式会社微生物化学研究所 | ヘモフィルス・パラガリナラムａ型菌由来の感染防御抗原である組み換え蛋白 |
| JP2008029589A (ja) | 2006-07-28 | 2008-02-14 | Fujishoji Co Ltd | 弾球遊技機 |
| JP2008156317A (ja) | 2006-12-26 | 2008-07-10 | Biseibutsu Kagaku Kenkyusho:Kk | アビバクテリウム・パラガリナラムｃ型菌由来の発症防御抗原である新規組換え蛋白 |
-
2009
- 2009-12-24 MX MX2011006903A patent/MX2011006903A/es active IP Right Grant
- 2009-12-24 EP EP20090834924 patent/EP2382985B1/en active Active
- 2009-12-24 KR KR1020117017233A patent/KR101652060B1/ko not_active Expired - Fee Related
- 2009-12-24 ES ES14197266.1T patent/ES2616533T3/es active Active
- 2009-12-24 BR BRPI0924068A patent/BRPI0924068A2/pt not_active IP Right Cessation
- 2009-12-24 WO PCT/JP2009/071398 patent/WO2010074126A1/ja active Application Filing
- 2009-12-24 ES ES09834924.4T patent/ES2537426T3/es active Active
- 2009-12-24 JP JP2010544112A patent/JP5568017B2/ja active Active
- 2009-12-24 EP EP14197266.1A patent/EP2853270B1/en active Active
- 2009-12-24 US US13/142,178 patent/US8647634B2/en not_active Expired - Fee Related
- 2009-12-24 CN CN200980157652.3A patent/CN102333539B/zh not_active Expired - Fee Related
-
2012
- 2012-09-14 US US13/616,255 patent/US20130183330A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2010074126A1 (ja) | 2012-06-21 |
| EP2853270A1 (en) | 2015-04-01 |
| EP2853270B1 (en) | 2017-02-08 |
| CN102333539B (zh) | 2014-06-25 |
| KR20110114600A (ko) | 2011-10-19 |
| ES2616533T3 (es) | 2017-06-13 |
| ES2537426T3 (es) | 2015-06-08 |
| KR101652060B1 (ko) | 2016-08-29 |
| WO2010074126A1 (ja) | 2010-07-01 |
| US20120003257A1 (en) | 2012-01-05 |
| EP2382985A4 (en) | 2013-05-29 |
| EP2382985A1 (en) | 2011-11-02 |
| BRPI0924068A2 (pt) | 2016-07-26 |
| EP2382985B1 (en) | 2015-05-06 |
| JP5568017B2 (ja) | 2014-08-06 |
| US8647634B2 (en) | 2014-02-11 |
| US20130183330A1 (en) | 2013-07-18 |
| CN102333539A (zh) | 2012-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009104074A3 (en) | Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells | |
| RU2011151877A (ru) | Пептиды, проникающие в клетку | |
| NZ599598A (en) | Hyperblebbing shigella strains | |
| NZ621868A (en) | Growth hormone polypeptides and methods of making and using same | |
| NZ618391A (en) | Antigenic tau peptides and uses thereof | |
| BRPI0511118A (pt) | polipeptìdeos de haemophilus influenzae não transcritos | |
| PH12012500849A1 (en) | Mycobacterial vaccines | |
| IN2015DN02553A (es) | ||
| NZ624533A (en) | Novel immunotherapy against several tumors including neuronal and brain tumors | |
| MX2011006903A (es) | Vacuna recombinante de coriza infecciosa aviar y procedimiento para preparar la misma. | |
| EP2628749A3 (en) | Antimicrobial kinocidin compostions and methods of use | |
| NZ708103A (en) | Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment | |
| UA107329C2 (uk) | Туберкульозний білок rv2386c, композиція, що його містить, та застосування | |
| WO2010150233A3 (en) | Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof | |
| MX2011011130A (es) | Proteina o peptido de fusion con vida media in vivo incrementada mantenido por liberacion in vivo sostenida, y metodo para incrementar la vida media in vivo usando el mismo. | |
| NZ591415A (en) | Haemophilus influenzae type B | |
| MX2011003502A (es) | Anticuerpo de cadena sencilla biespecifica de psmaxcd3 especifico a traves de especies. | |
| MX2012011405A (es) | Anticuerpo biespecifico psmaxcd3 de simple cadena especifico de especies cruzadas. | |
| EP2829550A3 (en) | Fusion proteins forming trimers | |
| NZ600732A (en) | Oxyntomodulin peptide analogue | |
| WO2012045082A3 (en) | Engineered nucleic acids and methods of use thereof | |
| PE20110310A1 (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas | |
| UA107330C2 (uk) | Туберкульозний білок rv3616c та його застосування | |
| UA107180C2 (uk) | Туберкульозний білок rv1753c, композиція, що його містить, та застосування | |
| EP3210622A3 (en) | Recombinant avian paramyxovirus vaccine and method for making and using thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |